Rheumatoid arthritis in Dubai--delayed diagnosis and low usage of disease modifying antirheumatic drugs.
作者信息
Badsha Humeira, Kong K Ooi, Tak P P
出版信息
Ann Rheum Dis. 2007 Jun;66(6):835. doi: 10.1136/ard.2006.068171.
Abstract
摘要
相似文献
1
Rheumatoid arthritis in Dubai--delayed diagnosis and low usage of disease modifying antirheumatic drugs.迪拜的类风湿性关节炎——诊断延迟与改善病情抗风湿药使用率低
Ann Rheum Dis. 2007 Jun;66(6):835. doi: 10.1136/ard.2006.068171.
2
Rheumatoid arthritis in the United Arab Emirates.阿拉伯联合酋长国的类风湿性关节炎。
Clin Rheumatol. 2008 Jun;27(6):739-42. doi: 10.1007/s10067-007-0782-z. Epub 2007 Nov 1.
3
Barriers to achieving controlled rheumatoid arthritis in the United Arab Emirates: a cross-sectional study.阿拉伯联合酋长国实现类风湿关节炎病情控制的障碍：一项横断面研究。
Rheumatol Int. 2015 Apr;35(4):759-63. doi: 10.1007/s00296-014-3151-7. Epub 2014 Oct 15.
4
Efforts to increase public awareness may result in more timely diagnosis of rheumatoid arthritis.努力提高公众的认识可能会导致类风湿关节炎的更及时诊断。
J Clin Rheumatol. 2012 Sep;18(6):279-82. doi: 10.1097/RHU.0b013e3182676975.
5
DNA methylation at diagnosis is associated with response to disease-modifying drugs in early rheumatoid arthritis.诊断时的DNA甲基化与早期类风湿关节炎中改善病情药物的反应相关。
Epigenomics. 2017 Apr;9(4):419-428. doi: 10.2217/epi-2016-0042. Epub 2016 Nov 25.
6
Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.抗风湿治疗对类风湿关节炎患者血脂水平的影响：一项前瞻性研究。
Am J Med. 2002 Aug 15;113(3):188-93. doi: 10.1016/s0002-9343(02)01186-5.
7
Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis?传统抗风湿病情改善药（DMARDs）在类风湿关节炎治疗中是否仍有作用？
Curr Opin Rheumatol. 2003 May;15(3):185-92. doi: 10.1097/00002281-200305000-00003.
8
[Reduction in the need for glucocorticoids on the background of therapy with biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis: evidence from real clinical practice].[类风湿关节炎中生物性疾病改善抗风湿药物和 Janus 激酶抑制剂治疗背景下糖皮质激素需求的减少：来自真实临床实践的证据]
Ter Arkh. 2024 Jun 3;96(5):465-470. doi: 10.26442/00403660.2024.05.202701.
9
Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients.在一个大型阿拉伯患者队列中，类风湿关节炎的流行病学和治疗模式。
PLoS One. 2018 Dec 19;13(12):e0208240. doi: 10.1371/journal.pone.0208240. eCollection 2018.
10
[The results of the baseline therapy of the rheumatoid arthritis].[类风湿关节炎的基础治疗结果]
Voen Med Zh. 2010 Aug;331(8):14-9.
引用本文的文献
1
Diagnostic Delay in Patients with Primary Sjögren's Syndrome: A Population-Based Cohort Study in Taiwan.原发性干燥综合征患者的诊断延迟：台湾一项基于人群的队列研究
Healthcare (Basel). 2021 Mar 23;9(3):363. doi: 10.3390/healthcare9030363.
2
Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East.托珠单抗治疗类风湿关节炎的安全性、耐受性和疗效：一项针对中东患者的开放标签4期研究。
Int J Rheumatol. 2015;2015:975028. doi: 10.1155/2015/975028. Epub 2015 May 19.
3
Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry.类风湿关节炎、银屑病关节炎和强直性脊柱炎患者的诊断延迟：来自丹麦全国性DANBIO注册中心的结果。
Ann Rheum Dis. 2015 Mar;74(3):e12. doi: 10.1136/annrheumdis-2013-204867. Epub 2014 Feb 17.
4
Lag time between onset of symptoms and diagnosis in Venezuelan patients with rheumatoid arthritis.委内瑞拉类风湿关节炎患者症状出现与诊断之间的时间延迟。
Rheumatol Int. 2011 May;31(5):657-65. doi: 10.1007/s00296-009-1358-9. Epub 2010 Jan 12.
5
The benefits of yoga for rheumatoid arthritis: results of a preliminary, structured 8-week program.瑜伽对类风湿性关节炎的益处：初步、结构化的 8 周方案的结果。
Rheumatol Int. 2009 Oct;29(12):1417-21. doi: 10.1007/s00296-009-0871-1. Epub 2009 Jan 31.
6
Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs.类风湿关节炎的治疗：抗风湿药物使用的全球视角
Mod Rheumatol. 2008;18(3):228-39. doi: 10.1007/s10165-008-0056-x. Epub 2008 Apr 25.
7
Rheumatoid arthritis in the United Arab Emirates.阿拉伯联合酋长国的类风湿性关节炎。
Clin Rheumatol. 2008 Jun;27(6):739-42. doi: 10.1007/s10067-007-0782-z. Epub 2007 Nov 1.
本文引用的文献
1
Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis.改善病情抗风湿药和生物制剂在类风湿关节炎中的疗效、耐受性及成本效益
Drugs. 2005;65(5):661-94. doi: 10.2165/00003495-200565050-00006.
2
The expression of rheumatoid arthritis in Kuwaiti patients in an outpatient hospital-based practice.科威特门诊医院患者中类风湿关节炎的表现。
Med Princ Pract. 2004 Jan-Feb;13(1):47-50. doi: 10.1159/000074052.
3
Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year.类风湿关节炎患者早期使用改善病情抗风湿药物治疗与第一年采用金字塔式治疗方法后的五年随访
Arthritis Rheum. 2003 Jul;48(7):1797-807. doi: 10.1002/art.11170.
4
Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.类风湿关节炎治疗反应的预测因素：疾病持续时间的重要性。
Arthritis Rheum. 2000 Jan;43(1):22-9. doi: 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9.
5
The expression of rheumatoid arthritis in Saudi Arabia.沙特阿拉伯类风湿关节炎的表现
Clin Rheumatol. 1995 Nov;14(6):641-5. doi: 10.1007/BF02207929.
6
Rheumatoid arthritis in a population sample in the Gulf: clinical observations.海湾地区人群样本中的类风湿性关节炎：临床观察
Clin Rheumatol. 1993 Dec;12(4):506-10. doi: 10.1007/BF02231780.
7
Reumatoid arthritis in Iraq.伊拉克的类风湿性关节炎。
Rheumatol Rehabil. 1977 May;16(2):128-32. doi: 10.1093/rheumatology/16.2.128.
Zotero 插件